Insightful Marketer

Self Testing Market  In-vitro diagnostics products offer non-invasive solutions for various diagnosis procedures. Products such as glucose monitoring kits, pregnancy test kits, ovulation prediction kits, COVID-19 test kits, and others can diagnose medical conditions from the samples collected non-invasively. Rising incidence of lifestyle diseases such as diabetes and growing demand for easy to use point-of-care testing solutions for preventative healthcare are propelling the growth of the market. The global in-vitro diagnostics market is estimated to be valued at US$ 89,432.58 million in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Rising demand for point-of-care testing is driving the growth of the self-testing market. Point-of-care testing enables convenient medical testing and quick results without visiting laboratories. It allows testing to be pe...

Schmallenberg Virus Treatment Market Schmallenberg virus (SBV) is an orthobunyavirus that affects domestic and wild ruminants such as cattle, sheep and goats. The virus causes fever, diarrhea and decreased milk production in adult animals. In newborn animals, the virus can lead to arthrogryposis-hydranencephaly syndrome, which causes malformations of the limbs and heads. While there is currently no treatment for SBV infection, supportive treatment measures such as nutritional supplements can help address symptoms such as diarrhea and reduced milk production. Researchers are developing preventive drugs and vaccines to control the spread of the virus. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity for growth in the Schmallenberg virus treatment marke...

Hyperthermia cancer treatment  Hyperthermia cancer treatment involves raising the temperature of tumours or the whole body to damage and kill cancer cells or sensitize them to other treatments such as chemotherapy and radiation therapy. The treatment makes use of devices that carefully raise the temperature of tumours and the surrounding tissues at targeted locations in the body. This can be done by using interstitial, intracavitary, or external hyperthermia depending on the location and size of the tumour. The treatment aims to make cancer cells more sensitive to radiation and chemotherapy by damaging their DNA. The global hyperthermia cancer treatment market is estimated to be valued at US$ 187.05 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising incidences of cancer across the globe pose a significant market opportunity for hyperther...